Počet záznamov: 1
Targeted strategy in lipid-lowering therapy
Názov Targeted strategy in lipid-lowering therapy Autor Saman Ezgi 1989- SAVNOPAT - Ústav normálnej a patologickej fyziológie SAV SCOPUS ORCID Spoluautori Pecháňová Oľga 1962- SAVNOPAT - Ústav normálnej a patologickej fyziológie SAV SCOPUS ORCID Zdroj.dok. Biomedicines. Vol. 10, no. 5 (2022), art. no. 1090, p. [1-18] Jazyk dok. eng - angličtina Krajina CH - Švajčiarsko URL URL link Druh dok. rozpis článkov z periodík (rbx) Ohlasy STANCIULESCU, Laura-Adina - SCAFA, Alexandru - DUDUIANU, Catalin - STAN, Raluca - NICOLESCU, Alina - DELEANU, Calin - DOROBANTU, Maria. Lipoprofiling Assessed by NMR Spectroscopy in Patients with Acute Coronary Syndromes: Is There a Need for Fasting Prior to Sampling? In DIAGNOSTICS, 2022, vol. 12, no. 7, art. no. 1675. Dostupné na: https://doi.org/10.3390/diagnostics12071675. BROGI, Simone - TABANELLI, Rita - CALDERONE, Vincenzo. Combinatorial approaches for novel cardiovascular drug discovery: a review of the literature. In EXPERT OPINION ON DRUG DISCOVERY, 2022, vol. 17, no. 10, p. 1111-1129, ISSN 1746-0441. Dostupné na: https://doi.org/10.1080/17460441.2022.2104247. LI, J.D. - XIONG, T. - WANG, T.Q. - WANG, M. - WANG, C. - YANG, F.Y. - WANG, X.D. - TAN, Z.J. - SUN, W.L. Baicalein targets CD36 to prevent foam cell formation by suppressing the excessive uptake of oxLDL and accelerating ABCA1-mediated cholesterol efflux in oxLDL-induced THP-1 macrophages. In JOURNAL OF FUNCTIONAL FOODS. ISSN 1756-4646, OCT 2022, vol. 97, art. no. 105253. QIAN, J.Y. - LI, Z.Q. - ZHANG, X.L. - CHEN, J.Y. - DING, C.H. - YANG, P. - LIU, Y. - SHI, M. - REN, X.R. - GE, J.B. Efficacy and Tolerability of Ezetimibe/Atorvastatin Fixed-dose Combination Versus Atorvastatin Monotherapy in Hypercholesterolemia: A Phase III, Randomized, Active-controlled Study in Chinese Patients. In CLINICAL THERAPEUTICS. ISSN 0149-2918, OCT 2022, vol. 44, no. 10, p. 1282-1296. OUYANG, M.Q. - LI, C.Y. - HU, D. - PENG, D.Q. - YU, B.L. Mechanisms of unusual response to lipid-lowering therapy: PCSK9 inhibition. In CLINICA CHIMICA ACTA. ISSN 0009-8981, JAN 1 2023, vol. 538, p. 113-123. RACHITHA, P. - KRISHNASWAMY, K. - LAZAR, R.A. - GUPTA, V.K. - INBARAJ, B.S. - RAGHAVENDRA, V.B. - SHARMA, M. - SRIDHAR, K. Attenuation of Hyperlipidemia by Medicinal Formulations of Emblica officinalis Synergized with Nanotechnological Approaches. In BIOENGINEERING-BASEL. JAN 2023, vol. 10, no. 1. BOUTARI, C. - RIZOS, C.V. - DOUMAS, M. - LIAMIS, G. - SKOUMAS, I. - RALLIDIS, L. - GAROUFI, A. - KOLOVOU, G. - TZIOMALOS, K. - SKALIDIS, E. - KOTSIS, V. - SFIKAS, G. - LAMBADIARI, V. - ANAGNOSTIS, P. - BILIANOU, E. - ANASTASIOU, G. - KOUTAGIAR, I. - KIOURI, E. - ATTILAKOS, A. - KOLOVOU, V. - ZACHARIS, E. - ANTZA, C. - LIBEROPOULOS, E. Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). In PHARMACEUTICALS. JAN 2023, vol. 16, no. 1. MONTELIONE, N. - LORENI, F. - NENNA, A. - CATANESE, V. - SCURTO, L. - FERRISI, C. - JAWABRA, M. - GABELLINI, T. - CODISPOTI, F.A. - SPINELLI, F. - CHELLO, M. - STILO, F. Tissue Engineering and Targeted Drug Delivery in Cardiovascular Disease: The Role of Polymer Nanocarrier for Statin Therapy. In BIOMEDICINES. MAR 2023, vol. 11, no. 3. PHAM, V. - MORONI, A. - GALL, E. - BENEDETTI, A. - ZIVELONGHI, C. - PICARD, F. Revascularization and Medical Therapy for Chronic Coronary Syndromes: Lessons Learnt from Recent Trials, a Literature Review. In JOURNAL OF CLINICAL MEDICINE. APR 2023, vol. 12, no. 8. SONG, Z.L. - MENG, S.Y. - TANG, Z. - YANG, X.X. - HE, Y. - ZHENG, Y. - GUO, H. - DU, M.R. - ZHU, Y.Z. - WANG, X.L. Injectable leonurine nanocrystal-loaded microspheres for long-term hyperlipidemia management. In BIOMATERIALS SCIENCE. ISSN 2047-4830, JUN 27 2023, vol. 11, no. 13, p. 4713-4726. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2022 Registrované v WOS Registrované v SCOPUS DOI 10.3390/biomedicines10051090 
článok
Názov súboru Prístup Veľkosť Stiahnuté Typ Licence Targeted strategy in lipid-lowering therapy.pdf Prístupný 2.9 MB 0 Vydavateľská verzia rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2022 2021 4.757 Q2 0.874 Q1
Počet záznamov: 1